Related Experiment Video
Updated: Dec 10, 2025

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Canine parvovirus induces G1/S cell cycle arrest that involves EGFR Tyr1086 phosphorylation
Xiaofeng Dai1,2, Xuanhao Zhang3, Yujie Miao
1Wuxi School of Medicine, Jiangnan University , Wuxi, China.
Abstract:
Canine parvovirus (CPV) has been used in cancer control as a drug delivery vehicle or anti-tumor reagent due to its multiple natural advantages. However, potential host cell cycle arrest induced by virus infection may impose a big challenge to CPV associated cancer control as it could prevent host cancer cells from undergoing cell lysis and foster them regain viability once the virotherapy was ceased. To explore CPV-induced cell cycle arrest and the underlying mechanism toward improved virotherapeutic design, we focus on epidermal growth factor receptor (EGFR), a cellular receptor interacting with TfR that mediates CPV-host interactions, and alterations on its tyrosine phosphorylation sites in response to CPV infection. We found that CPV could trigger host G1/S cell cycle arrest via the EGFR (Y1086)/p27 and EGFR (Y1068)/STAT3/cyclin D1 axes, and EGFR inhibitor could not reverse this process. Our results contribute to our understandings on the mechanism of CPV-induced host cellular response and can be used in the onco-therapeutic design utilizing CPV by preventing host cancer cells from entering cell cycle arrest.
Insights
Canine parvovirus (CPV) causes cancer cell cycle arrest via EGFR signaling, hindering cancer therapy. Understanding this mechanism helps improve oncolytic virus design for better cancer control.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- Canine parvovirus (CPV) shows promise as an oncolytic agent and drug delivery system.
- CPV-induced cell cycle arrest in cancer cells poses a challenge to virotherapy efficacy.
- Understanding CPV's interaction with host cell machinery is crucial for optimizing cancer treatment.
Purpose of the Study:
- To investigate the mechanism of CPV-induced G1/S cell cycle arrest in host cancer cells.
- To explore the role of epidermal growth factor receptor (EGFR) in CPV-mediated cell cycle modulation.
- To inform the design of improved CPV-based cancer therapies.
Main Methods:
- Analysis of CPV infection effects on host cell cycle progression.
- Investigating tyrosine phosphorylation sites on EGFR following CPV infection.
- Examining the EGFR (Y1086)/p27 and EGFR (Y1068)/STAT3/cyclin D1 signaling pathways.
- Assessing the impact of EGFR inhibitors on CPV-induced cell cycle arrest.
Main Results:
- CPV infection triggers a G1/S cell cycle arrest in host cancer cells.
- The cell cycle arrest is mediated through specific EGFR phosphorylation sites and downstream signaling pathways (EGFR (Y1086)/p27 and EGFR (Y1068)/STAT3/cyclin D1).
- EGFR inhibitors were unable to reverse the CPV-induced cell cycle arrest.
Conclusions:
- CPV actively manipulates host cell cycle regulation via EGFR signaling.
- The identified pathways provide mechanistic insight into CPV's anti-cancer effects and limitations.
- This knowledge can guide the development of oncolytic virotherapies that overcome cell cycle arrest for enhanced cancer treatment.
More Related Videos
12:02Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Related Concept Videos
Negative Regulator Molecules
Inhibition of Cdk Activity
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Mitogens and the Cell Cycle
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...